Forian Inc (FORA) - Net Assets
Based on the latest financial reports, Forian Inc (FORA) has net assets worth $31.08 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($41.25 Million) and total liabilities ($10.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check FORA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $31.08 Million |
| % of Total Assets | 75.34% |
| Annual Growth Rate | N/A |
| 5-Year Change | 166.73% |
| 10-Year Change | N/A |
| Growth Volatility | 75.16 |
Forian Inc - Net Assets Trend (2019–2024)
This chart illustrates how Forian Inc's net assets have evolved over time, based on quarterly financial data. Also explore Forian Inc total assets for the complete picture of this company's asset base.
Annual Net Assets for Forian Inc (2019–2024)
The table below shows the annual net assets of Forian Inc from 2019 to 2024. For live valuation and market cap data, see FORA market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $30.05 Million | +8.41% |
| 2023-12-31 | $27.72 Million | +123.15% |
| 2022-12-31 | $12.42 Million | -50.65% |
| 2021-12-31 | $25.17 Million | +123.40% |
| 2020-12-31 | $11.27 Million | +4109.21% |
| 2019-12-31 | $-281.03K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Forian Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4862626800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $31.01K | 0.10% |
| Other Components | $79.94 Million | 265.99% |
| Total Equity | $30.05 Million | 100.00% |
Forian Inc Competitors by Market Cap
The table below lists competitors of Forian Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Luks Kadife Ticaret ve Sanayi AS
IS:LUKSK
|
$65.28 Million |
|
Ensurge Micropower ASA
OL:ENSU
|
$65.29 Million |
|
Me2on Co. Ltd
KQ:201490
|
$65.29 Million |
|
Atari S.A.
PA:ALATA
|
$65.31 Million |
|
Accelerate Property Fund Ltd
JSE:APF
|
$65.22 Million |
|
Cauldron Energy Ltd
AU:CXU
|
$65.18 Million |
|
Data Communications Management Ltd
TO:DCM
|
$65.18 Million |
|
Nickel 28 Capital Corp
V:NKL
|
$65.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Forian Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 27,721,180 to 30,053,016, a change of 2,331,836 (8.4%).
- Net loss of 3,771,070 reduced equity.
- Share repurchases of 292,900 reduced equity.
- Other factors increased equity by 6,395,806.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.77 Million | -12.55% |
| Share Repurchases | $292.90K | -0.97% |
| Other Changes | $6.40 Million | +21.28% |
| Total Change | $- | 8.41% |
Book Value vs Market Value Analysis
This analysis compares Forian Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-0.01 | $2.16 | x |
| 2020-12-31 | $0.38 | $2.16 | x |
| 2021-12-31 | $0.79 | $2.16 | x |
| 2022-12-31 | $0.39 | $2.16 | x |
| 2023-12-31 | $0.86 | $2.16 | x |
| 2024-12-31 | $0.97 | $2.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Forian Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.55%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18.71%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 1.57x
- Recent ROE (-12.55%) is above the historical average (-55.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.26 Million |
| 2020 | -44.20% | -914.01% | 0.04x | 1.11x | $-6.11 Million |
| 2021 | -105.48% | -157.30% | 0.30x | 2.26x | $-29.07 Million |
| 2022 | -209.07% | -158.19% | 0.35x | 3.72x | $-27.21 Million |
| 2023 | 40.07% | 54.23% | 0.34x | 2.20x | $8.33 Million |
| 2024 | -12.55% | -18.71% | 0.43x | 1.57x | $-6.78 Million |
Industry Comparison
This section compares Forian Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $363,436,353
- Average return on equity (ROE) among peers: -160.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Forian Inc (FORA) | $31.08 Million | 0.00% | 0.33x | $65.25 Million |
| Aclarion Inc (ACON) | $2.23 Million | -317.55% | 0.31x | $1.99 Million |
| American Well Corp (AMWL) | $480.19 Million | -140.60% | 0.23x | $90.87 Million |
| Heartbeam Inc (BEAT) | $-26.87 Million | 0.00% | 0.00x | $30.37 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-3.06 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $612.55 Million | -25.24% | 8.03x | $8.82 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-70.63 Million | 0.00% | 0.00x | $253.42 Million |
| CareCloud Inc. (CCLD) | $101.25 Million | -8.70% | 0.36x | $117.28 Million |
| Certara Inc (CERT) | $492.05 Million | -1.81% | 1.11x | $983.48 Million |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $1.99 Billion | 0.49% | 3.21x | $277.75 Million |
About Forian Inc
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data ma… Read more